LOINC long common name : Ebola Zaire virus RNA [Presence] in Plasma or Blood by NAA with probe detection;
LOINC short name : EZ1 RNA PlasBld Ql NAA probe;
LOINC description : The Ebola Zaire PCR assay presumptively detects Ebola Zaire virus, a single-stranded
RNA virus identified in the 2014 West Africa outbreak. The assay is used for testing
individuals with signs and symptoms of Ebola virus infection, those who are at risk
for or may have been exposed to the Ebola Zaire virus, or in accordance with current
public health recommendations. The definitive identification of the Ebola Zaire virus
requires additional testing and confirmation procedures in consultation with public
health. This term was developed for, but is not limited to, use with the Ebola Zaire
Target 1 (EZ1) real-time reverse transcription (rRT) polymerase chain reaction (TaqMan
) assay (EZ1 assay), which is run on plasma or whole blood specimens. As of August
2014, the EZ1 assay is approved for use under an FDA Emergency Use Authorization (EUA)
[http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM408334.pdf]
by specified laboratories and clinical laboratory personnel who have been trained
on instruments authorized by the U.S. Department of Defense.;